HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alexander Burges Selected Research

atezolizumab

12/2020Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alexander Burges Research Topics

Disease

45Neoplasms (Cancer)
12/2022 - 11/2005
44Ovarian Neoplasms (Ovarian Cancer)
05/2022 - 12/2006
9Ovarian Epithelial Carcinoma
01/2022 - 12/2006
6Ascites
11/2010 - 11/2005
5Carcinoma (Carcinomatosis)
03/2020 - 03/2010
4Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 01/2011
4Breast Neoplasms (Breast Cancer)
12/2021 - 01/2010
3Endometrial Neoplasms (Endometrial Cancer)
12/2022 - 09/2017
2Granulosa Cell Tumor
02/2021 - 08/2019
2Carcinogenesis
01/2020 - 10/2011
2Residual Neoplasm
01/2009 - 12/2006
1Pre-Eclampsia (Preeclampsia)
01/2022
1COVID-19
12/2021
1Neoplasm Metastasis (Metastasis)
06/2021
1Uterine Neoplasms (Uterine Cancer)
08/2020
1Thrombocytosis (Thrombocythemia)
01/2020
1Body Weight (Weight, Body)
12/2019
1Disease Progression
12/2019

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
05/2022 - 03/2008
11PlatinumIBA
05/2022 - 09/2010
8Biomarkers (Surrogate Marker)IBA
05/2022 - 12/2012
7Pharmaceutical PreparationsIBA
05/2022 - 12/2008
7Carboplatin (JM8)FDA LinkGeneric
01/2022 - 02/2009
4Bevacizumab (Avastin)FDA Link
12/2020 - 07/2017
4Paclitaxel (Taxol)FDA LinkGeneric
01/2020 - 12/2009
4AntigensIBA
01/2019 - 11/2005
4Nelfinavir (Viracept)FDA Link
10/2010 - 12/2008
4HIV Protease InhibitorsIBA
10/2010 - 12/2008
3DNA (Deoxyribonucleic Acid)IBA
01/2022 - 08/2008
3Sirtuin 1IBA
01/2022 - 08/2020
3Protein Isoforms (Isoforms)IBA
01/2021 - 03/2008
3catumaxomabIBA
11/2010 - 07/2007
3Epithelial Cell Adhesion MoleculeIBA
11/2010 - 11/2005
2Biological ProductsIBA
05/2022 - 01/2020
2CateninsIBA
06/2021 - 08/2020
2Estrogen ReceptorsIBA
01/2021 - 12/2018
2Small Interfering RNA (siRNA)IBA
01/2021 - 01/2020
2LigandsIBA
01/2021 - 12/2009
2B7-H1 AntigenIBA
12/2020 - 03/2020
2FSH Receptors (FSH Receptor)IBA
10/2019 - 06/2019
2Messenger RNA (mRNA)IBA
01/2019 - 12/2018
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 03/2008
2lonafarnib (SCH 66336)IBA
11/2015 - 08/2012
2Tumor Biomarkers (Tumor Markers)IBA
09/2011 - 04/2009
2Hormones (Hormone)IBA
01/2010 - 01/2007
2AnnexinsIBA
01/2010 - 12/2008
2TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
12/2009 - 12/2008
1Sialyl Lewis X AntigenIBA
12/2022
1Blood Group Antigens (Blood Groups)IBA
12/2022
1CA-19-9 Antigen (CA 19-9 Antigen)IBA
12/2022
1Galectins (Galectin)IBA
10/2022
1treosulfanIBA
05/2022
1ResveratrolIBA
01/2022
1Retinoid X Receptors (Retinoid X Receptor)IBA
01/2022
1histone H3 trimethyl Lys4IBA
01/2022
12019-nCoV Vaccine mRNA-1273IBA
12/2021
1ChAdOx1 nCoV-19IBA
12/2021
1COVID-19 VaccinesIBA
12/2021
1Platelet Activating FactorIBA
06/2021
1EnzymesIBA
06/2021
1IntegrinsIBA
03/2021
1Sirtuin 3IBA
02/2021
1platelet activating factor receptorIBA
01/2021
1Glucose (Dextrose)FDA LinkGeneric
01/2021
1Phosphopyruvate Hydratase (Enolase)IBA
01/2021
1Estrogens (Estrogen)FDA Link
01/2021
1rupatadineIBA
01/2021
1GTP-Binding Proteins (G-Protein)IBA
01/2021
1atezolizumabIBA
12/2020
1Calcitriol Receptors (Calcitriol Receptor)IBA
10/2020
1CalciumIBA
10/2020
1Vitamin DFDA LinkGeneric
10/2020
1ParaffinIBA
08/2020
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2020
1Mucin-1 (CA 15-3 Antigen)IBA
01/2020
1Complementary DNA (cDNA)IBA
01/2020
1beta-Arrestin 1IBA
01/2020
1nintedanibIBA
01/2020
1human ERBB2 proteinIBA
01/2020
1TabletsIBA
12/2019
1taxaneIBA
12/2019
1olaparibIBA
12/2019
1ProstaglandinsIBA
10/2019
1Galectin 1 (LGALS1)IBA
10/2019
1Programmed Cell Death 1 ReceptorIBA
08/2019
1CaspasesIBA
08/2019
1Inhibitor of Apoptosis ProteinsIBA
08/2019
1Indicators and Reagents (Reagents)IBA
07/2019
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
06/2019
1Immune Checkpoint InhibitorsIBA
05/2019
1thiaclopridIBA
01/2019
1Progesterone Receptors (Progesterone Receptor)IBA
01/2019
1progesterone receptor AIBA
01/2019
1progesterone receptor BIBA
01/2019

Therapy/Procedure

17Therapeutics
05/2022 - 03/2010
12Drug Therapy (Chemotherapy)
05/2022 - 01/2009
4Immunotherapy
03/2021 - 11/2005
3Cytoreduction Surgical Procedures
08/2016 - 12/2006
2Brachytherapy
01/2022 - 09/2018
2Lymph Node Excision (Lymph Node Dissection)
01/2019 - 01/2019